Tesamorelin IU Per Tick Insulin Syringe — Dose Precision

The most common mistake when reconstituting tesamorelin isn't contamination. It's assuming insulin syringe tick marks translate directly to International Units (IU) without accounting for the peptide's reconstituted concentration. A standard U-100 insulin syringe delivers 1 IU per tick mark when used with U-100 insulin, but tesamorelin vials don't arrive pre-mixed at U-100 concentration. The IU per tick depends entirely on how much bacteriostatic water you add during reconstitution. And getting that calculation wrong compounds across every injection for weeks.

Our team has guided hundreds of research protocols through peptide reconstitution. The gap between doing it right and doing it wrong comes down to three things most guides never mention: final concentration math, syringe type selection, and verifying your calculation before the first draw.

How many IU of tesamorelin does each tick mark on an insulin syringe deliver?

Each tick mark on a U-100 insulin syringe represents 1 IU when the syringe contains U-100 insulin, but for reconstituted tesamorelin, the IU per tick depends on your final peptide concentration. If you reconstitute 2mg tesamorelin with 2mL bacteriostatic water, the concentration is 1mg/mL. Meaning 10 tick marks (0.1mL) delivers 100mcg, not 10 IU. The tick mark measures volume, not peptide mass.

The confusion stems from insulin's unique standardisation. U-100 insulin is formulated so that 1mL contains exactly 100 units of insulin. A U-100 syringe is calibrated to that specific concentration. Tesamorelin and other research peptides are measured by mass (milligrams or micrograms), not by standardised biological units. When you reconstitute a lyophilised peptide, you're creating a custom concentration that has no relationship to the U-100 insulin standard. This article covers exactly how to calculate the correct tesamorelin IU per tick insulin syringe measurement for your specific reconstitution, which syringe types avoid measurement errors, and what preparation mistakes create dosing drift across multi-week protocols.

Understanding Tesamorelin Reconstitution and Concentration

Tesamorelin arrives as lyophilised powder in vials labelled by total peptide mass. Typically 2mg per vial. The peptide is biologically inactive in powder form and must be reconstituted with bacteriostatic water to create an injectable solution. The volume of water you add determines the final concentration, and that concentration determines how much tesamorelin is delivered per tick mark on your insulin syringe.

Standard reconstitution uses 2mL bacteriostatic water per 2mg vial, yielding a concentration of 1mg/mL (1,000mcg/mL). At this concentration, each 0.1mL (10 tick marks on a U-100 syringe) contains 100mcg of tesamorelin. Clinical trials for visceral adipose reduction typically use doses between 1mg and 2mg administered subcutaneously once daily. If you reconstitute the same 2mg vial with only 1mL water instead, the concentration doubles to 2mg/mL, and each 10 tick marks now delivers 200mcg instead of 100mcg.

The calculation is straightforward: (total peptide mass in mcg) ÷ (total reconstitution volume in mL) = concentration in mcg/mL. Then divide your target dose in mcg by the concentration to find the required injection volume in mL. Convert mL to tick marks by multiplying by 100 (since each tick on a U-100 syringe is 0.01mL). Researchers who skip this step and assume 'one tick equals one unit' consistently underdose or overdose depending on their arbitrary reconstitution volume.

Syringe Type and Tick Mark Calibration

Not all insulin syringes use the same tick spacing. U-100 syringes are the standard, with each tick representing 0.01mL (1 unit when filled with U-100 insulin). A full 1mL U-100 syringe holds 100 tick marks. U-40 syringes exist but are less common. They're calibrated for U-40 insulin (40 units per mL) and have wider tick spacing. Using a U-40 syringe with a peptide reconstituted for U-100 measurement will result in a 2.5× dosing error.

The most reliable syringe for reconstituted peptides is the 1mL U-100 insulin syringe with a 27G or 29G needle. The 0.5mL and 0.3mL versions have the same tick calibration but smaller total capacity. The key is matching your reconstitution concentration to a syringe size that allows precise measurement without requiring you to draw near the syringe's maximum capacity.

Meniscus error becomes significant when reading tick marks near the syringe's capacity limit. A researcher drawing 0.9mL from a 1mL syringe is reading the meniscus at the top of the barrel, where even a 0.01mL error represents a 1% dose variation. Drawing 0.45mL from the same syringe places the meniscus in the barrel's center, where the same absolute error is a smaller percentage of total dose. Reconstitute at a concentration that keeps your injection volume between 0.2mL and 0.6mL for optimal accuracy.

Tesamorelin IU Per Tick Insulin Syringe: Worked Calculation Examples

Example 1: Standard 2mg vial reconstituted with 2mL bacteriostatic water.
Concentration = 2mg ÷ 2mL = 1mg/mL = 1,000mcg/mL.
Target dose = 1mg = 1,000mcg.
Required volume = 1,000mcg ÷ 1,000mcg/mL = 1mL = 100 tick marks.
Each tick delivers 10mcg of tesamorelin.

Example 2: Same 2mg vial reconstituted with 1mL bacteriostatic water (higher concentration).
Concentration = 2mg ÷ 1mL = 2mg/mL = 2,000mcg/mL.
Target dose = 1mg = 1,000mcg.
Required volume = 1,000mcg ÷ 2,000mcg/mL = 0.5mL = 50 tick marks.
Each tick delivers 20mcg of tesamorelin.

Example 3: 5mg vial reconstituted with 2mL bacteriostatic water.
Concentration = 5mg ÷ 2mL = 2.5mg/mL = 2,500mcg/mL.
Target dose = 2mg = 2,000mcg.
Required volume = 2,000mcg ÷ 2,500mcg/mL = 0.8mL = 80 tick marks.
Each tick delivers 25mcg of tesamorelin.

These examples demonstrate that the tesamorelin IU per tick insulin syringe measurement is not fixed. It's a function of your reconstitution choice. Higher concentration means fewer tick marks per dose but higher peptide mass per tick. Lower concentration spreads the same dose across more tick marks, improving measurement precision for small dose adjustments but requiring larger injection volumes.

What If: Tesamorelin Dosing Scenarios

What If I Reconstitute With the Wrong Volume by Accident?

Recalculate immediately using the actual volume added. If you intended 2mL but added 2.5mL, your concentration is now 0.8mg/mL instead of 1mg/mL. Each 10 ticks delivers 80mcg instead of 100mcg. Adjust your tick count for each dose: to deliver 1mg, draw 125 ticks instead of 100. Do not discard the vial unless the volume error is so extreme that your target dose exceeds the syringe's capacity. Label the vial with the actual concentration immediately.

What If My Target Dose Is Between Tick Marks?

Round to the nearest tick mark. Attempting to split a single tick visually introduces more error than the rounding itself. If your calculated dose is 87 tick marks, use either 85 or 90 depending on your protocol's tolerance. For research requiring finer dose precision, reconstitute at a higher concentration so that smaller dose increments correspond to full tick marks.

What If I'm Using a Pre-Filled Multi-Dose Vial From a Compounding Source?

Request the exact concentration from the compounder before calculating tick marks. Compounded tesamorelin vials are often prepared at non-standard concentrations (e.g., 1.5mg/mL or 3mg/mL) to optimise injection volume. If the concentration isn't labelled, contact the pharmacy directly. Guessing creates dosing error that accumulates across the entire vial. Once you have the concentration, apply the same calculation: (target dose in mcg) ÷ (concentration in mcg/mL) × 100 = tick marks.

The Unforgiving Truth About Peptide Dosing Precision

Here's the honest answer: most peptide dosing errors don't come from reconstitution contamination or injection technique. They come from researchers assuming insulin syringes are universal measurement tools without doing the concentration math. We've reviewed protocols where the same 2mg tesamorelin vial was reconstituted with volumes ranging from 1mL to 4mL across different users, each assuming their tick marks delivered identical doses. They didn't. A 4× difference in reconstitution volume creates a 4× difference in dose per tick, and that error persists across every injection until the vial is empty.

The standard U-100 insulin syringe is calibrated for one thing: U-100 insulin. Using it for any other injectable compound requires explicit concentration calculation, and that calculation must be verified before the first draw. Tesamorelin's efficacy window for visceral fat reduction in clinical trials spans 1–2mg daily. A narrow range where underdosing by 30% eliminates measurable effect and overdosing by 50% increases adverse event risk without additional benefit.

Lyophilised peptides are stable and forgiving during storage, but once reconstituted, every dose must be measured with precision because the compounding error of repeated incorrect draws eliminates any therapeutic consistency. A researcher who miscalculates tick marks and administers 1.3mg daily instead of 1mg for 12 weeks isn't running a 1mg protocol. They're running an uncontrolled dose escalation study with unknown endpoints.

We see this most often when researchers switch vial sizes mid-protocol without recalculating. A 2mg vial reconstituted with 2mL becomes habit: '100 ticks equals my dose.' Then they receive a 5mg vial, reconstitute with 2mL out of habit, and continue drawing 100 ticks. Now delivering 2.5mg instead of 1mg without realising it. Label every vial with its actual concentration in mg/mL immediately after reconstitution, and recalculate tick marks every time you prepare a new vial. Muscle memory is not a substitute for arithmetic.

For researchers working across multiple peptide compounds. Tesamorelin, sermorelin, ipamorelin. This problem compounds. Each peptide arrives at different vial sizes, each gets reconstituted at researcher preference, and each requires independent tick mark calculation. Our recommendation: create a dosing reference card for each peptide batch that lists vial size, reconstitution volume, final concentration, and tick marks per target dose. Verify it before every draw.

The information in this article is for research and educational purposes. Dosage decisions and reconstitution protocols should be designed and supervised by qualified research personnel or licensed medical professionals.

Tesamorelin's mechanism. Selective growth hormone secretagogue receptor (GHS-R) agonism that increases endogenous GH pulsatility. Makes it uniquely valuable for visceral adipose reduction studies. But the mechanism is dose-dependent. Subtherapeutic dosing (below 1mg daily in most adult protocols) produces statistically insignificant reductions in VAT, and supratherapeutic dosing above 2mg doesn't improve efficacy but increases injection site reactions and transient hyperglycaemia risk. The therapeutic window exists, and hitting it requires dose precision that starts with correct tesamorelin IU per tick insulin syringe calculation at reconstitution.

Research-grade peptides like those in Real Peptides' inventory ship as lyophilised powder specifically because it's the most stable form for transport and storage. Reconstitution is the researcher's responsibility, and so is the math. The trade-off is calculation responsibility, and that responsibility is non-negotiable if dose precision matters to your protocol.

The reality: peptide research doesn't fail because the compounds don't work. It fails because dosing inconsistency eliminates the ability to interpret results. If you're not certain how much tesamorelin each tick mark delivers in your current vial, stop drawing and recalculate now. The data you collect with incorrect dosing is scientifically meaningless. Dose precision starts with reconstitution math. Get that right, and everything downstream becomes interpretable.

FAQs

How do I calculate tesamorelin IU per tick insulin syringe for my vial?
Divide the total peptide mass in micrograms by the reconstitution volume in millilitres to get concentration in mcg/mL. Then divide your target dose in micrograms by that concentration to find the required injection volume in mL. Multiply by 100 to convert to tick marks on a U-100 syringe. Example: 2mg vial + 2mL water = 1,000mcg/mL; for a 1mg dose, you need 1mL = 100 ticks.

Can I use a U-40 insulin syringe for reconstituted tesamorelin?
No. U-40 syringes have different tick spacing calibrated for U-40 insulin (40 units per mL), and using them with peptides reconstituted for U-100 measurement creates a 2.5× dosing error. Always use U-100 insulin syringes (clearly labelled on the syringe package) for peptide protocols to ensure tick marks correspond to 0.01mL per tick.

What happens if I draw tesamorelin using the wrong tick count?
You'll administer either more or less peptide than intended, and that error will repeat across every subsequent injection until corrected. Tesamorelin's therapeutic range is narrow. Underdosing by 20–30% eliminates measurable efficacy in visceral fat reduction, and overdosing increases injection site reactions and transient hyperglycaemia without improving outcomes. Recalculate immediately using your actual reconstitution volume.

Does tesamorelin concentration affect potency or stability after reconstitution?
Concentration affects only the volume required per dose, not the peptide's biological activity. A 1mg/mL solution and a 2mg/mL solution deliver identical effects if the injected peptide mass is the same. However, more dilute solutions (below 0.5mg/mL) may have slightly reduced stability over the standard 28-day refrigerated use period due to increased surface-area-to-peptide-mass ratio. Stick to 1–2mg/mL for optimal stability.

Should I reconstitute tesamorelin with bacteriostatic water or sterile water?
Bacteriostatic water is required for multi-dose vials because it contains 0.9% benzyl alcohol, which prevents bacterial growth during the vial's use period. Sterile water lacks preservatives and must be used within 24 hours of reconstitution. For tesamorelin protocols spanning multiple weeks from a single vial, bacteriostatic water is the only appropriate diluent.

What's the maximum number of times I can draw from a single reconstituted tesamorelin vial?
There's no hard limit, but each needle puncture introduces potential contamination and slightly degrades the rubber stopper. Most vials tolerate 20–30 punctures without issue when proper aseptic technique is maintained. For protocols requiring more frequent dosing, consider reconstituting at higher concentration to reduce total injection volume and the number of required draws per vial.

Can I pre-fill syringes with tesamorelin for an entire week of doses?
Not recommended. Pre-filled syringes lose sterility over time even when capped, and peptide adhesion to syringe walls can reduce delivered dose by 5–15% after 48 hours. Draw each dose fresh from the refrigerated vial immediately before injection to maintain both sterility and dose accuracy.

How do I verify my tesamorelin concentration calculation is correct before starting a protocol?
Double-check by working backwards: multiply your planned tick count by 0.01mL to get injection volume, then multiply that volume by your calculated concentration to get delivered peptide mass in micrograms. The result should equal your target dose. If it doesn't match within 1–2%, recalculate from scratch. Write the calculation on the vial label for reference during subsequent draws.

What syringe size is best for tesamorelin injections?
A 1mL U-100 insulin syringe with a 27G or 29G needle is optimal for most protocols. The 1mL capacity accommodates dose volumes between 0.2mL and 0.9mL, and the 27G/29G needles balance injection comfort with adequate flow rate for viscous solutions. Smaller 0.5mL or 0.3mL syringes work for low-dose protocols where total injection volume is under 0.3mL.

Does the tick mark on an insulin syringe represent IU for all injectable medications?
No. Tick marks represent volume (0.01mL per tick on U-100 syringes), which translates to 1 IU only when the syringe contains U-100 insulin specifically. For all other injectables including peptides, the 'IU per tick' depends entirely on the solution's concentration. Never assume tick marks equal IU for non-insulin compounds.

If I switch from a 2mg vial to a 5mg vial mid-protocol, do I need to recalculate tick marks?
Yes. Unless you reconstitute the 5mg vial at exactly 2.5× the volume used for the 2mg vial to maintain identical concentration. If you reconstituted the 2mg vial with 2mL and the 5mg vial with 2mL, the concentrations are different (1mg/mL vs 2.5mg/mL), and your tick count must change. Recalculate for every new vial unless you're certain the concentration matches your previous preparation.

Can I use tesamorelin reconstitution math for other peptides like sermorelin or ipamorelin?
Yes. The calculation method is identical for all lyophilised peptides. Divide total peptide mass by reconstitution volume to find concentration, then divide target dose by concentration to find required injection volume. Convert mL to tick marks by multiplying by 100. Each peptide requires its own calculation based on its vial size and your chosen reconstitution volume.